Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab. [electronic resource] by
- Pierobon, M
- Silvestri, A
- Spira, A
- Reeder, A
- Pin, E
- Banks, S
- Parasido, Erika
- Edmiston, K
- Liotta, L
- Petricoin, E
Producer: 20150122
In:
Journal of proteome research vol. 13
Availability: No items available.
|
|
5.
|
Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability. [electronic resource] by
- Ruggieri, V
- Pin, E
- Russo, M T
- Barone, F
- Degan, P
- Sanchez, M
- Quaia, M
- Minoprio, A
- Turco, E
- Mazzei, F
- Viel, A
- Bignami, M
Producer: 20131114
In:
Oncogene vol. 32
Availability: No items available.
|
|
6.
|
HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer. [electronic resource] by
- Lai, C-H
- Park, K-S
- Lee, D-H
- Alberobello, A T
- Raffeld, M
- Pierobon, M
- Pin, E
- Petricoin Iii, E F
- Wang, Y
- Giaccone, G
Producer: 20141126
In:
Oncogene vol. 33
Availability: No items available.
|